SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Sonesitatug Vedotin Granted Priority Review in the US

The application covers second- and later-line treatment of patients with CLDN18.2-positive advanced gastric or gastroesophageal junction cancers.

Related stories